Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Cook

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Psychiatry|August 10, 2005
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*DJon S Novick, Jonathan W Stewart, Stephen R Wisniewski, et al.
Psychiatry Research|August 29, 2009
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD studyAndrew F Leuchter, Ian A Cook, Lauren B Marangell, et al.
The Journal of Clinical Psychiatry|October 2, 2014
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up periodDavid L Dunner, Scott T Aaronson, Harold A Sackeim, et al.
Current Psychiatry Reports|October 22, 2010
Biomarkers to predict antidepressant responseAndrew F Leuchter, Ian A Cook, Steven P Hamilton, et al.
The American Journal of Psychiatry|May 4, 2011
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized studyA John Rush, Madhukar H Trivedi, Jonathan W Stewart, et al.
The Journal of Clinical Psychiatry|March 6, 2018
Dr McClintock and Colleagues ReplyShawn M McClintock, Irving M Reti, Linda L Carpenter, et al.
The Journal of Clinical Psychiatry|May 26, 2017
Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of DepressionShawn M McClintock, Irving M Reti, Linda L Carpenter, et al.
Archives of Neurology|October 11, 2002
Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjectsIan A Cook, Andrew F Leuchter, Melinda L Morgan, et al.
JAMA Internal Medicine|October 7, 2024
Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical TrialConstance H Fung, Cathy Alessi, Jennifer L Martin, et al.
Journal of Mood and Anxiety Disorders|June 15, 2026
Real-world evidence of SAINT® effectiveness in a heterogenous clinical population with psychiatric and medical comorbidities: A multicenter, open-label, community-based studyMichael T Feyder, Katy H Stimpson, Andrew D Geoly, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Psychiatry|August 10, 2005
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*DJon S Novick, Jonathan W Stewart, Stephen R Wisniewski, et al.
Psychiatry Research|August 29, 2009
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD studyAndrew F Leuchter, Ian A Cook, Lauren B Marangell, et al.
The Journal of Clinical Psychiatry|October 2, 2014
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up periodDavid L Dunner, Scott T Aaronson, Harold A Sackeim, et al.
Current Psychiatry Reports|October 22, 2010
Biomarkers to predict antidepressant responseAndrew F Leuchter, Ian A Cook, Steven P Hamilton, et al.
The American Journal of Psychiatry|May 4, 2011
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized studyA John Rush, Madhukar H Trivedi, Jonathan W Stewart, et al.
The Journal of Clinical Psychiatry|March 6, 2018
Dr McClintock and Colleagues ReplyShawn M McClintock, Irving M Reti, Linda L Carpenter, et al.
The Journal of Clinical Psychiatry|May 26, 2017
Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of DepressionShawn M McClintock, Irving M Reti, Linda L Carpenter, et al.
Archives of Neurology|October 11, 2002
Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjectsIan A Cook, Andrew F Leuchter, Melinda L Morgan, et al.
JAMA Internal Medicine|October 7, 2024
Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical TrialConstance H Fung, Cathy Alessi, Jennifer L Martin, et al.
Journal of Mood and Anxiety Disorders|June 15, 2026
Real-world evidence of SAINT® effectiveness in a heterogenous clinical population with psychiatric and medical comorbidities: A multicenter, open-label, community-based studyMichael T Feyder, Katy H Stimpson, Andrew D Geoly, et al.
Pageof 13